Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Antibiotika bei Infektionen mit multiresistenten Erregern [[electronic resource] /] / herausgegeben von Sebastian Schulz-Stübner, Frauke Mattner, Elisabeth Meyer, Rolf Mahlberg
| Antibiotika bei Infektionen mit multiresistenten Erregern [[electronic resource] /] / herausgegeben von Sebastian Schulz-Stübner, Frauke Mattner, Elisabeth Meyer, Rolf Mahlberg |
| Edizione | [1st ed. 2016.] |
| Pubbl/distr/stampa | Berlin, Heidelberg : , : Springer Berlin Heidelberg : , : Imprint : Springer, , 2016 |
| Descrizione fisica | 1 online resource (160 p.) |
| Disciplina | 610 |
| Soggetto topico |
Infectious diseases
Pharmacotherapy Critical care medicine Surgery Infectious Diseases Intensive / Critical Care Medicine |
| ISBN | 3-662-48060-3 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | ger |
| Nota di contenuto | 1. Leitsätze der Antibiotikatherapie -- 2. Checkliste MRE-Infektionen -- 3. Generika - Handelsnamen -- 4. Handelsnamen - Generika.- 5. Einleitung -- 6. MRSA-Infektionen -- 7. VRE-Infektionen -- 8.Multiresistente gramnegative Bakterien -- 9 MDR-TB -- 10. Wichtige Substanzen.-. |
| Record Nr. | UNINA-9910483972903321 |
| Berlin, Heidelberg : , : Springer Berlin Heidelberg : , : Imprint : Springer, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antimicrobial Drug Resistance [[electronic resource] ] : Mechanisms of Drug Resistance, Volume 1 / / edited by Douglas L. Mayers, Jack D. Sobel, Marc Ouellette, Keith S. Kaye, Dror Marchaim
| Antimicrobial Drug Resistance [[electronic resource] ] : Mechanisms of Drug Resistance, Volume 1 / / edited by Douglas L. Mayers, Jack D. Sobel, Marc Ouellette, Keith S. Kaye, Dror Marchaim |
| Edizione | [2nd ed. 2017.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017 |
| Descrizione fisica | 1 online resource (XXI, 773 p. 164 illus., 61 illus. in color.) |
| Disciplina | 616.9041 |
| Soggetto topico |
Drug resistance
Infectious diseases Drug Resistance Infectious Diseases |
| ISBN | 3-319-46718-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | History of Drug-Resistant Microbes -- Evolutionary Biology of Drug Resistance -- Pharmacology of Drug Resistance -- Drug Development for Drug-Resistant Pathogens -- Genetic Mechanisms of Transfer of Drug Resistance -- Mutations as a Basis of Antimicrobial Resistance -- Altered Drug Targets -- Enzymatic Modification of Drugs -- Reduced Drug Penetration -- Active Efflux Mechanism -- Biofilms -- Beta-Lactamases -- Penicillin Binding Proteins -- Aminoglycosides -- Tetracyclines and ChloramphenicolQuinolones -- Plasmid Mediated Quinolone Resistance to Macrolides, Lincosamides, and Streptogramins -- Mechanisms of Resistance in Metronidazole -- Glycopeptide-resistance in eneterococci -- Daptomycin Resistance -- Oxazolidinones -- PolymyxinsSulfonamides and Trimethoprim -- Antimycobacterial Agents -- Amphotericin (Polyenes) -- Azoles -- Flucytosine -- Echinocandins -- Antifungal Targets, Mechanisms of Action, and Resistance in Candida albicans -- Herpes Nucleoside Drugs -- Influenza Drugs -- HIV Nucleoside Drugs -- HIV Non-Nucleoside Drugs -- HIV Protease Inhibitors -- HIV Entry Inhibitors -- HIV Integrase Inhibitors -- Hepatitis B -- Hepatitis C -- Agents for anaerobic protozoa -- Antimalarial Agents -- Agents for Leishmania -- Agents for Trypanosomes -- Agents for Toxoplasma -- Agents for Cryptosporidium -- Agents against Nematodes -- Agents against Trematodes and Cestodes -- Agents against Ectoparasites. . |
| Record Nr. | UNINA-9910253931003321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antimicrobial Drug Resistance [[electronic resource] ] : Clinical and Epidemiological Aspects, Volume 2 / / edited by Douglas L. Mayers, Jack D. Sobel, Marc Ouellette, Keith S. Kaye, Dror Marchaim
| Antimicrobial Drug Resistance [[electronic resource] ] : Clinical and Epidemiological Aspects, Volume 2 / / edited by Douglas L. Mayers, Jack D. Sobel, Marc Ouellette, Keith S. Kaye, Dror Marchaim |
| Edizione | [2nd ed. 2017.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017 |
| Descrizione fisica | 1 online resource (XXI, 855 p. 61 illus., 32 illus. in color.) |
| Disciplina | 616.9041 |
| Soggetto topico |
Drug resistance
Infectious diseases Drug Resistance Infectious Diseases |
| ISBN | 3-319-47266-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | History of Drug-Resistant Microbes -- Evolutionary Biology of Drug Resistance -- Pharmacology of Drug Resistance -- Drug Development for Drug-Resistant Pathogens -- Genetic Mechanisms of Transfer of Drug Resistance -- Mutations as a Basis of Antimicrobial Resistance -- Altered Drug Targets -- Enzymatic Modification of Drugs -- Reduced Drug Penetration -- Active Efflux Mechanism -- Biofilms -- Beta-Lactamases -- Penicillin Binding Proteins -- Aminoglycosides -- Tetracyclines and ChloramphenicolQuinolones -- Plasmid Mediated Quinolone Resistance to Macrolides, Lincosamides, and Streptogramins -- Mechanisms of Resistance in Metronidazole -- Glycopeptide-resistance in eneterococci -- Daptomycin Resistance -- Oxazolidinones -- PolymyxinsSulfonamides and Trimethoprim -- Antimycobacterial Agents -- Amphotericin (Polyenes) -- Azoles -- Flucytosine -- Echinocandins -- Antifungal Targets, Mechanisms of Action, and Resistance in Candida albicans -- Herpes Nucleoside Drugs -- Influenza Drugs -- HIV Nucleoside Drugs -- HIV Non-Nucleoside Drugs -- HIV Protease Inhibitors -- HIV Entry Inhibitors -- HIV Integrase Inhibitors -- Hepatitis B -- Hepatitis C -- Agents for anaerobic protozoa -- Antimalarial Agents -- Agents for Leishmania -- Agents for Trypanosomes -- Agents for Toxoplasma -- Agents for Cryptosporidium -- Agents against Nematodes -- Agents against Trematodes and Cestodes -- Agents against Ectoparasites. |
| Record Nr. | UNINA-9910253931103321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antimicrobial Peptides and Innate Immunity [[electronic resource] /] / edited by Pieter S. Hiemstra, Sebastian A. J. Zaat
| Antimicrobial Peptides and Innate Immunity [[electronic resource] /] / edited by Pieter S. Hiemstra, Sebastian A. J. Zaat |
| Edizione | [1st ed. 2013.] |
| Pubbl/distr/stampa | Basel : , : Springer Basel : , : Imprint : Springer, , 2013 |
| Descrizione fisica | 1 online resource (387 p.) |
| Disciplina | 615.329 |
| Collana | Progress in Inflammation Research |
| Soggetto topico |
Immunology
Infectious diseases Biochemistry Medical microbiology Infectious Diseases Biochemistry, general Medical Microbiology |
| ISBN |
1-299-33633-7
3-0348-0541-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Evolution of Antimicrobial Peptides: a View From the Cystine Chapel -- Innate immunity in plants: the role of antimicrobial peptides -- Antimicrobial peptides produced by microorganisms -- LL-37: an immunomodulatory antimicrobial host defence peptide -- Wound Repair and Antimicrobial Peptides -- WAPing out pathogens and disease in the mucosa-roles for SLPI and trappin-2 -- Histatins: multifunctional salivary antimicrobial peptides -- Structure-function relationships of antimicrobial chemokines -- Mechanisms and Significance of Bacterial Resistance to Human Cationic Antimicrobial Peptides -- Antimicrobial peptides and inflammatory bowel disease -- Cystic Fibrosis and Defective Airway Innate Immunity -- Antimicrobial peptides in chronic obstructive pulmonary disease -- Host defense peptides: Immune modulation and antimicrobial activity in vivo -- Helping the host – induction of antimicrobial peptides as a novel therapeutic strategy against infections. |
| Record Nr. | UNINA-9910437996803321 |
| Basel : , : Springer Basel : , : Imprint : Springer, , 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antimicrobial Resistance in the 21st Century [[electronic resource] /] / edited by I. W. Fong, David Shlaes, Karl Drlica
| Antimicrobial Resistance in the 21st Century [[electronic resource] /] / edited by I. W. Fong, David Shlaes, Karl Drlica |
| Edizione | [2nd ed. 2018.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018 |
| Descrizione fisica | 1 online resource (773 pages) |
| Disciplina | 616.90461 |
| Collana | Emerging Infectious Diseases of the 21st Century |
| Soggetto topico |
Immunology
Infectious diseases Microbiology Virology Epidemiology Public health Infectious Diseases Public Health |
| ISBN | 3-319-78538-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter1: Introduction : Coordinated Global Action is Needed to Combat Antimicrobial Resistance -- Part I: Examples of Resistance -- Chapter2: Antimicrobial Resistance Among Streptococcus pneumoniae -- Chapter3: Emergence of MRSA in the Community -- Chapter4: Resistance of Gram-negative Bacilli to Antimicrobials -- Chapter5: Drug Resistance in Tuberculosis -- Chapter6: Anaerobic Bacteria: Antimicrobial Susceptibility Testing and Resistance Patterns -- Chapter7: Clinical Significance and Biologic Basis of HIV Drug Resistance -- Chapter8: Resistance of Herpesviruses to Antiviral Agents -- Chapter9: Heteroresistance: A Harbinger of Future Resistance -- Part II: Biology of Resistance -- Chapter10: Epidemiology of Bacterial Resistance -- Chapter11: Transmissible Antibiotic Resistance -- Chapter12: Antibiotics and Resistance in the Environment -- Chapter13: Phenotypic Tolerance and Bacterial Persistence -- Chapter14: Staphylococcus aureus Adaptation During Infection -- Chapter15: Bacterial Signal Transduction Systems in Antimicrobial Resistance -- Chapter16: Fluoroquinolone Interactions with Bacterial Type II Topoisomerases and Target-mediated Drug Resistance -- Part III: Finding New Antimicrobials -- Chapter17: Natural Products in Antibiotic Discovery -- Chapter18: The New vs. Old Target Debate For Drug Discovery -- Chapter19: Non-quinolone Topoisomerase Inhibitors -- Chapter20: Antimicrobial-Mediated Bacterial Suicide -- Chapter21: PK/PD-based Prediction of “Anti-mutant” Antibiotic Exposures Using In Vitro Dynamic Models -- Part IV: Bringing Compounds to Market -- Chapter22: The Role of Pharmacometrics in the Development of Antimicrobial Agents -- Chapter23: New Regulatory Pathways for Antibacterial Drugs -- Chapter24: Economic Incentives for Antibacterial Drug Development: Alternative Market Structures to Promote Innovation. |
| Record Nr. | UNINA-9910300300803321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antimicrobials [[electronic resource] ] : New and Old Molecules in the Fight Against Multi-resistant Bacteria / / edited by Flavia Marinelli, Olga Genilloud
| Antimicrobials [[electronic resource] ] : New and Old Molecules in the Fight Against Multi-resistant Bacteria / / edited by Flavia Marinelli, Olga Genilloud |
| Edizione | [1st ed. 2014.] |
| Pubbl/distr/stampa | Berlin, Heidelberg : , : Springer Berlin Heidelberg : , : Imprint : Springer, , 2014 |
| Descrizione fisica | 1 online resource (363 p.) |
| Disciplina |
610
615.7 616.9 616.9041 |
| Soggetto topico |
Medical microbiology
Drug resistance Infectious diseases Microbiology Medical Microbiology Drug Resistance Infectious Diseases Applied Microbiology |
| ISBN | 3-642-39968-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Preface""; ""Contents""; ""Part ICurrent Trends in Antibiotics, Pathogens and Medical Needs""; ""1 The Origin and Evolution of Antibiotics""; ""Abstract""; ""1.1�Introduction""; ""1.2�What�s in a Name?""; ""1.3�Many Sources, Uses, and Functions""; ""1.4�How Old Are ��Antibiotics��?""; ""1.5�Antibiotic Myths""; ""1.6�Mode of Action and Evolution of Targets""; ""1.7�Parallel Chemical and Protein Evolution""; ""1.8�Conclusions""; ""References""
""2 Novel Infectious Diseases and Emerging Gram-Positive Multi-Resistant Pathogens in Hospital and Community Acquired Infections""""Abstract""; ""2.1�Introduction""; ""2.2�Methicillin-Resistant S. aureus as a Cause of HospitalHospital- and Community-Acquired InfectionsCommunity-Acquired Infections""; ""2.3�Infections Caused by Glycopeptide-Resistant EnterococciEnterococci""; ""2.4�Issues with Clostridium difficileClostridium difficile Infections""; ""2.5�Conclusions""; ""3 Gram-Negative Pathogens: Overview of Novel and Emerging Resistant Pathogens and Drugs""; ""Abstract"" ""3.1�Introduction""""3.2�MDR, XDR and PDR Pathogens, and Resistance Mechanisms""; ""3.2.1 Resistance to beta -Lactam Antibiotics""; ""3.2.2 Resistance to Aminoglycosides""; ""3.2.3 Resistance to Tigecycline""; ""3.2.4 Resistance to Fluoroquinolones""; ""3.2.5 Resistance to Colistin""; ""3.2.6 Resistance to Phosphonic Acid Derivatives""; ""3.3�Emerging Gram-Negative Resistant Pathogens""; ""3.3.1 Pseudomonas aeruginosa""; ""3.3.1.1 Antibiotic Resistance Mechanisms""; ""3.3.1.2 Risk Factors for Infections and Resistance Development""; ""3.3.2 Acinetobacter baumannii"" ""3.3.2.1 Antibiotic Resistance Mechanisms""""3.3.2.2 Risk Factors for Infections and Resistance Development""; ""3.3.3 Enterobacteriaceae and Klebsiella pneumoniae""; ""3.3.3.1 Antibiotic Resistance Mechanisms""; ""3.3.3.2 Risk Factors for Infections and Resistance Development""; ""3.3.3.3 Klebsiella pneumoniae""; ""3.4�The Complexity of the Resistance Problem""; ""3.4.1 Novel Antimicrobials""; ""3.4.2 Novel beta -Lactam and beta -Lactamase Inhibitors""; ""3.4.2.1 Novel Cephalosporins""; ""3.4.2.2 Novel Carbapenems""; ""3.4.2.3 Novel Monobactams"" ""3.4.2.4 Novel beta -Lactamase Inhibitors""""3.4.3 Novel Non beta -Lactam Antibiotic Compounds""; ""3.4.3.1 Compounds Belonging to Known Class of Antimicrobial Agents""; ""3.4.3.2 Compounds Which Represent New Classes of Antimicrobials""; ""3.5�Conclusions""; ""References""; ""Part IIFamilies of Novel Candidates and Conventional Antibiotics""; ""4 The beta -Lactam Antibiotics: Their Future in the Face of Resistance""; ""Abstract""; ""4.1�Introduction""; ""4.2�Recent Advances in the Chemistry of the beta -Lactams""; ""4.2.1 New Cephalosporins"" ""4.2.1.1 Latest Generation Cephalosporins"" |
| Record Nr. | UNINA-9910298309303321 |
| Berlin, Heidelberg : , : Springer Berlin Heidelberg : , : Imprint : Springer, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antiseptic Stewardship [[electronic resource] ] : Biocide Resistance and Clinical Implications / / by Günter Kampf
| Antiseptic Stewardship [[electronic resource] ] : Biocide Resistance and Clinical Implications / / by Günter Kampf |
| Autore | Kampf Günter |
| Edizione | [1st ed. 2018.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018 |
| Descrizione fisica | 1 online resource (722 pages) |
| Disciplina | 614.48 |
| Soggetto topico |
Medical microbiology
Infectious diseases Environmental health Medical Microbiology Infectious Diseases Environmental Health |
| ISBN | 3-319-98785-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. Chemical characterization -- 2. Types of application -- 2a. Approval by ECHA -- 2b. Approval by EPA -- 2c. Amounts per type of application (overall environmental impact) -- 3. Spectrum of antimicrobial activity -- 3a. Bactericidal activity -- 3b. Fungicidal activity -- 3c. Mycobactericidal activity -- 3d. Virucidal activity -- 3e. Sporicidal activity -- 4. Natural resistances -- 5. Adaptation after exposure -- 5a. Per type of typical application -- 6. 7. Cross-resistance to other biocidal agents -- 8. Cross-resistances to antibiotics -- 9. Proposal for responsible use (antiseptic stewardship). |
| Record Nr. | UNINA-9910298412003321 |
Kampf Günter
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Arthropod Borne Diseases [[electronic resource] /] / edited by Carlos Brisola Marcondes
| Arthropod Borne Diseases [[electronic resource] /] / edited by Carlos Brisola Marcondes |
| Edizione | [1st ed. 2017.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017 |
| Descrizione fisica | 1 online resource (XXIV, 645 p. 158 illus., 137 illus. in color.) |
| Disciplina | 616.9 |
| Soggetto topico |
Infectious diseases
Parasitology Pathology Entomology Veterinary medicine Infectious Diseases Veterinary Medicine/Veterinary Science |
| ISBN | 3-319-13884-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. General comments and importance of arthropod-related diseases -- 2. Epidemiology of vector-borne diseases -- 3. Blood sucking insects and history -- 4. Blood sucking, vector-parasite relationship and transmission of diseases -- 5. Generalities on arboviruses -- 6. Yellow fever -- 7. Dengue -- 8. Other flaviviruses -- 9. Togaviridae -- 10. Bunyaviruses -- 11. Plague and tularemia -- 12. Rickettsial infections, Bartonella infections and coxiellosis -- 13. Borreliosis: Lyme disease and relapsing fever -- 14. Ehrlichiosis -- 15. Anaplasmosis -- 16. Leishmaniasis -- 17. American trypanosomiasis (Chagas disease) -- 18. Sleeping sickness, nagana -- 19. Other trypanosomiasis -- 20. Malaria -- 21. Babesiosis -- 22. Theileriosis -- 23. Hepatozoonosis -- 24. Lymphatic filariasis -- 25. Onchocerciasis -- 26. Mansonelliasis -- 27. Dirofilariasis -- 28. Loiasis -- 29. Thelaziosis (canine eye-worm) -- 30. Habronemosis -- 31. Flies -- 32. Sucking and biting lice -- 33. Fleas -- 34. Diseases caused by Acari (ticks and mites) -- 35. Other irritating Arthropods (beetles, bugs, centipedes etc.) -- 36. Allergy to bites of hematophagous arthropods -- 37. Geoprocessing and expected distribution of diseases (including deforestation, global warming and other changes) -- 38. Wolbachia: influence on pathogeny, treatment and control of arthropod borne diseases. |
| Record Nr. | UNINA-9910150453203321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Autophagy Networks in Inflammation [[electronic resource] /] / edited by Maria Chiara Maiuri, Daniela De Stefano
| Autophagy Networks in Inflammation [[electronic resource] /] / edited by Maria Chiara Maiuri, Daniela De Stefano |
| Edizione | [1st ed. 2016.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2016 |
| Descrizione fisica | 1 online resource (XV, 403 p. 20 illus., 16 illus. in color.) |
| Disciplina | 616.079 |
| Collana | Progress in Inflammation Research |
| Soggetto topico |
Immunology
Cell biology Infectious diseases Cell Biology Infectious Diseases |
| ISBN | 3-319-30079-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Autophagy in direct pathogen elimination (Xenophagy) -- Autophagy and pattern recognition receptors -- Autophagy and inflammasomes -- Autophagy and Antigen presentation -- Autophagy and regulation of T and B cell function -- Autophagy in chronic inflammation -- The complex crosstalk between autophagy and ROS -- Lipophagy -- Autophagy, phagocytosis and entosis: who eats whom?- Which is the cell fate of inflammatory cells ? Autophagic cell death, pyroptosis, netosis, apoptosis, necrosis -- Host defence (virus/bacteria) -- Neurological diseases -- Pulmonary diseases (emphysema, COPD, etc.) -- Inflammatory bowel disease -- Target autophagy as a novel therapeutic strategy in autoimmune diseases -- Liver and pancreatic diseases -- Obesity -- Aging -- Overview on clinical trials. |
| Record Nr. | UNINA-9910254520303321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Bacterial Activation of Type I Interferons [[electronic resource] /] / edited by Dane Parker
| Bacterial Activation of Type I Interferons [[electronic resource] /] / edited by Dane Parker |
| Edizione | [1st ed. 2014.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2014 |
| Descrizione fisica | 1 online resource (133 p.) |
| Disciplina |
579.3
616.9 |
| Soggetto topico |
Bacteriology
Immunology Infectious diseases Infectious Diseases |
| ISBN | 3-319-09498-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Production and action of type I interferons in host defense -- Induction and consequences of the type I IFN response to Listeria monocytogenes -- Innate immune and type I IFN responses during Legionella pneumophila infection -- Type I interferons in immune defense against streptococci -- Activation of type I IFN signaling by Staphylococcus aureus -- Contribution of interferon signaling to host defense against Pseudomonas aeruginosa -- The detrimental role of type I interferon signaling during infection with Salmonella typhimurium -- Yersinia activation of type I interferon -- Induction and Function of Type I IFNs During Chlamydial Infection -- Regulation of Host Response to Mycobacteria by Type I Interferons. |
| Record Nr. | UNINA-9910298329203321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Soggetto topico
-
Infectious diseases
(320)
- Infectious Diseases (313)
- Immunology (77)
- Medical Microbiology (70)
- Medical microbiology (70)